ARTICLE | Company News
Bellvitge, Oxford Immunotec Global deal
September 7, 2015 7:00 AM UTC
Bellvitge granted Oxford exclusive rights to use B cell-measuring technology to develop and commercialize one or more diagnostics to measure the risk of transplant rejection. Bellvitge declined to pro...